Proteomics International: Raises $6M for high-tech blood test

  • Proteomics International (PIQ) has received firm commitments to undertake a $6 million share placement
  • 12.5 million shares will issued to sophisticated and professional investors at 48 cents each
  • Additionally, the company will issue 2.2 million options to Euroz Hartleys Securities and Candour Advisory
  • These options will have an exercise price of 75 cents with expiry two years after issue
  • Proteomics will also use the funds to manufacture, market, and speed-up regulatory approvals for its PromarkerD test and strengthen its balance sheet
  • Proteomics is up 9 per cent on the market with shares trading for 60 cents each
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Crypto Network Mesh Hits Unicorn Status as Valuation Soars

The rapidly growing crypto network achieves a billion-dollar valuation milestone.Highlights: Crypto network Mesh achieved unicorn status after recent...

FCA Launches Pop-Up ATM to Warn Customers of Investment Scams

New initiative aims to educate the public on investment fraud risks. Highlights:FCA introduces a pop-up ATM to combat...

Lloyds Strengthens AI Strategy After Assessing Financial Value of Deployments

The bank plans to enhance its artificial intelligence capabilities further.Highlights: Lloyds assesses the financial value of its AI...

Santander Tightens Operations with Closure of 44 More Branches

The bank continues its restructuring as customer preferences shift to digital banking.Highlights: Santander is closing 44 more branches...